2 results match your criteria: "Chi Feng Municipal Hospital[Affiliation]"
Integrating bioinformatics and machine learning to uncover lncRNA LINC00269 as a key regulator in Parkinson's disease via pyroptosis pathways.
Eur J Med Res
December 2024
Department of Neurology, The First Affiliated Hospital of Harbin Medical University, Number 23, You Zheng Street, Nan Gang District, Harbin, 150001, Heilongjiang Province, China.
Background: Pyroptosis, a specific type of programmed cell death, which has become a significant factor to Parkinson's disease (PD). Concurrently, long non-coding RNAs (lncRNAs) have garnered attention for their regulatory roles in neurodegenerative disorders. This study was designed to ascertain the key lncRNAs in pyroptosis pathways of PD and elucidate their regulatory mechanisms.
View Article and Find Full Text PDFDevelopment of clinical trials for non-small cell lung cancer drugs in China from 2005 to 2023.
Front Med (Lausanne)
November 2023
Clinical Science of Stomatology, Chi Feng Municipal Hospital, Chifeng, China.
Objective: Over the past few decades, the development of anti-cancer drugs in China has made outstanding achievements based on the support of national policies. To assess the progress of non-small cell lung cancer (NSCLC) drugs, we conducted a statistical analysis of clinical trials of drugs targeting NSCLC in China from 2005 to 2023.
Methods: We downloaded, screened and analysed the data from three official websites, the Centre for Drug Evaluation of China National Medical Products Administration website (NMPA), ClinicalTrials.